WCBA
AMSG

Weaver C. Barksdale & Associates’s Amsurg Corp AMSG Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio AMSG Stock Details AMSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-203
Closed -$14K – 549
2016
Q3 		$14K Buy
203
+39
+24% +$2.73K 0.02% 202
2016
Q2 		$13K Buy
164
+20
+14% +$1.55K 0.02% 191
2016
Q1 		$11K Buy
144
+25
+21% +$1.76K 0.01% 254
2015
Q4 		$9K Buy
+119
New +$9.42K 0.01% 287

Other funds holding AMSG

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Weaver C. Barksdale & Associates's AMSG Position: Q4 2016 in Review

Weaver C. Barksdale & Associates sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 203 shares — an estimated $14K sold.

Weaver C. Barksdale & Associates first reported a position in AMSG in Q4 2015 and held it in 4 quarters. The position peaked at $14K in Q3 2016. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

  • Weaver C. Barksdale & Associates reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 203 Amsurg Corp shares in Q4 2016, an estimated $14K.
  • Weaver C. Barksdale & Associates first reported a position in Amsurg Corp in Q4 2015 and held it in 4 quarters.
  • Weaver C. Barksdale & Associates's Amsurg Corp position peaked at $14K in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.